https://nsc122758agonist.com/a....-data-driven-approac
From October 2016 to December 2019, a cohort of 238 non-small cell lung cancer (NSCLC) patients participated in this investigation. Patient characteristics, encompassing age, gender, smoking history, histology types, tumor stage, survival status, and survival time, were gathered from electronic medical records or through telephone interviews. Employing the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) technique, 21 somatic muta
Synes godt om
Kommentar
Del
